Pranav, Author at Wellthy Therapeutics

Author Archives: Pranav

Harnessing Digital Health to Address the Multifaceted Impact of Alopecia on Health and Society

Introduction Alopecia is a condition that leads to hair loss. It can affect either the scalp or the entire body, and it may be temporary or permanent. The term encompasses a range of conditions, with varying etiologies, patterns, and clinical presentations.[1] The most common forms include Androgenetic Alopecia (male or female pattern hair loss), Alopecia

From Insight to Impact: TruDoc Acquires Wellthy Therapeutics to Deliver Premier Digital Health Services in the GCC and Expand to India

  Dubai, United Arab Emirates, February 2024: In a landmark move that promises to transform digital healthcare, TruDoc Healthcare, the GCC’s premier virtual primary care provider, is thrilled to announce its acquisition of Wellthy Therapeutics. Wellthy Therapeutics, Asia’s leading clinically validated chronic disease management platform, joins forces with TruDoc, creating new standards in healthcare outcome,

The Role of Continuous Glucose Monitoring (CGM) in Behavioral Interventions for Diabetes Management

Introduction Diabetes, a chronic condition characterized by elevated blood sugar levels, stands as one of the most pressing health challenges of the 21st century[1]. Globally, it affects millions, transcending geographical, cultural, and socioeconomic boundaries. Its management is a complex interplay of medical treatment, lifestyle choices, and continuous monitoring, with the latter often being a cornerstone

Empowering Patients and Preventing Hospitalizations with Digital Therapeutics

As technology continues to advance at a rapid pace, the way we approach patient care is undergoing a remarkable transformation, and digital therapeutics (DTx) are at the forefront of this revolution.  DTx are proven to have a profound impact on the way patients manage health conditions, and one of their most significant contributions is the

The Intersection of Type 2 Diabetes and Obesity: Pathways, Challenges, and Digital Health Solutions

Introduction: The prevalence of Type 2 Diabetes Mellitus (T2DM) and obesity has been rising at an alarming rate globally, presenting a critical public health challenge, with both conditions often coexisting and exacerbating each other.[1] This position paper aims to explore the crossover between T2DM and obesity, highlighting the interconnected physiological, genetic, and lifestyle factors that

Advancing IBS Care in the Digital Era: Global Challenges, Innovative Solutions, and Future Perspectives

Introduction: Irritable bowel syndrome (IBS) is a globally prevalent gastrointestinal disorder, affecting a significant portion of the world’s population. This chronic condition is characterized by a constellation of symptoms, including abdominal discomfort, bloating, and irregular bowel movements, which can range from diarrhea to constipation. The global burden of IBS is substantial, with countless individuals experiencing

Gamification in DTx: Revolutionizing Patient Engagement and Payer ROI

​​In the ever-evolving landscape of healthcare and technology, a promising approach has emerged to bridge the gap between traditional medical interventions and engaging patient experiences: Digital Therapeutics Gamification, often referred to as DTx gamification. This innovative concept not only offers new avenues for improving patient outcomes but also presents opportunities for healthcare payers to optimize

DTx in Clinical Trials: The Ultimate Guide

  Digital therapeutics (DTx) are revolutionizing the landscape of clinical trials, offering innovative approaches to recruitment, patient engagement, data collection, and much more. This comprehensive guide explores how DTx is transforming each phase of clinical trials, ensuring more efficient, accurate, and participant-friendly processes. Recruitment and Enrollment Targeted Outreach: Leveraging digital platforms for participant identification. Pre-screening

Payers Transitioning to Value-Based Contracting: The Essential Role of Digital Therapeutics in Pharma Differentiation

  The life sciences industry is undergoing a major transition, driven by calls for more equitable access to medications and the need for drugs that deliver long-term value. Patients, payers, and legislators alike are pushing for change, signaling the end of the fixed cost-per-unit model and ushering in the era of value-based contracts (VBCs). With

Leveraging Digital Health in the Journey of Multiple Sclerosis: Diagnosis, Treatment, and Beyond

This position paper explores the pivotal role of digital health technologies in revolutionizing the management of Multiple Sclerosis (MS). The paper sheds light on the complex challenges MS patients endure and the sophisticated diagnostic processes they face. It then delves into the transformative potential of Software as a Medical Device (SaMD) and other digital tools in providing personalized care, enhancing patient monitoring, and fostering a comprehensive treatment paradigm. The conclusive remarks emphasize the collaborative dynamic among healthcare professionals, patients, and technology developers, advocating for a future where digital health interventions substantially improve the quality of life for those living with MS.